The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clinical trial

A probiotic modulates the microbiome and immunity in multiple sclerosis

(2018) Stephanie K. Tankou et al.   ANNALS OF NEUROLOGY

Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis

(2018) Emily Evans et al.   JAMA Neurology

The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial

(2017) Omid Reza Tamtaji et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

(2017) Maria Pia Amato et al.   Multiple Sclerosis Journal

Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

(2017) Maria Pia Amato et al.   Multiple Sclerosis Journal

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial

(2017) Judit Villar-García et al.   PLoS One

Effect of a Mediterranean type diet on inflammatory and cartilage degradation biomarkers in patients with osteoarthritis

(2016) J. Dyer et al.   Journal of Nutrition Health & Aging

Alterations of the human gut microbiome in multiple sclerosis

(2016) Sushrut Jangi et al.   Nature Communications

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls

(2016) Jun Chen et al.   Scientific Reports

Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis

(2015) Jessica M. Yano et al.   CELL

Gut microbiota and obesity

(2015) Philippe Gérard   CELLULAR AND MOLECULAR LIFE SCIENCES

Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial

(2015) Annelise C. Costanza et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Gut Microbiota in Multiple Sclerosis

(2015) Brandi L. Cantarel et al.   JOURNAL OF INVESTIGATIVE MEDICINE

The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment

(2015) Xuan Zhang et al.   NATURE MEDICINE

Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters

(2015) Sachiko Miyake et al.   PLoS One

Digesting the emerging role for the gut microbiome in central nervous system demyelination

(2014) Jennifer Joscelyn et al.   Multiple Sclerosis Journal

Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis

(2014) Justin D Crane et al.   NATURE MEDICINE

Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

(2014) P. Browne et al.   NEUROLOGY

Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale

(2012) Sayonara Rangel Oliveira et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Saccharomyces boulardii Improves Intestinal Epithelial Cell Restitution by Inhibiting αvβ5 Integrin Activation State

(2012) Alexandra Canonici et al.   PLoS One

Combined Fruit and Vegetable Intake Is Correlated with Improved Inflammatory and Oxidant Status from a Cross-Sectional Study in a Community Setting

(2012) Martin M. Root et al.   Nutrients

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination

(2011) Kerstin Berer et al.   NATURE

Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders

(2011) Theodoros Kelesidis et al.   Therapeutic Advances in Gastroenterology

Recent advances in Saccharomyces boulardii research

(2010) E. Im et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

Systematic review and meta-analysis ofSaccharomyces boulardiiin adult patients

(2010) Lynne V McFarland   WORLD JOURNAL OF GASTROENTEROLOGY

Review article: anti-inflammatory mechanisms of action ofSaccharomyces boulardii

(2009) C. POTHOULAKIS   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

Saccharomyces boulardiiinhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation

(2009) S. Thomas et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis

(2009) J. Ochoa-Reparaz et al.   JOURNAL OF IMMUNOLOGY